Placebo: Difference between revisions

From BurnZero
mNo edit summary
mNo edit summary
Line 3: Line 3:


=== '''Why does the placebo effect exist?''' ===
=== '''Why does the placebo effect exist?''' ===
A key evolutionary selective aspect is the speed of response to stimuli. The quicker an organism reacts to seeing a lion, the higher its rate of survival and its genes perpetuate through that specific species. You can imagine this development much like an arms race, the mutating genes come up with new ways to quickly respond to stimuli. The initial messenger systems from abiogenesis were simple chemical messengers. i.e. there was stimuli, a chemical (such as an endogenous hormone) was released which caused some sort of response.
A key aspect of evolutionary success is the speed at which organisms respond to stimuli. Faster reactions increase survival rates, allowing those genes to persist in the species. This development is likened to an arms race, where genetic mutations evolve to enhance quick responses. Initially, simple chemical messengers were used, triggered by stimuli and resulting in responses, such as hormone release.


Over time chemical messaging was improved upon, a mechanism which could communicate at the speed of light was invented called the neuron. The neuron was innervated at one end and could send an electrical pulse to the other allowing the organism to respond in near real time. However, even real-time wasn't good enough. With the development of the neuron came higher thought, and the brain developed to become a predicting machine. The organism understood time in such a way it could extrapolate where a stimulus was going to interact with it even before it came near to it. This massive competitive advantage pushed species with larger brains to the top of the food chain and resulted in us.
Over time, evolution improved these systems, leading to the creation of neurons, which could send electrical signals at incredible speed. Neurons allowed organisms to react in near real-time. However, evolution pushed further, and the brain developed into a predictive machine. Instead of just reacting, organisms could anticipate where a stimulus would occur, allowing them to respond even before the threat arrived. This ability gave species with larger brains, including humans, a significant competitive advantage in survival.


Where placebo comes in is almost a hack of this predictive machine. To make a prediction and act on it the subconscious needs the brain needs to believe the stimulus is real. If the interpretation of this stimulus entered conscious thought it would then go through processing cycles which would end up wasting time, time in which you are being eaten by the lion. So the selective force kept this mechanism in the subconscious and tethered it to bypassing the ruminating brain.
The placebo effect taps into this predictive mechanism. For the brain to make a quick prediction and act on it, the subconscious must believe the stimulus is real. If the stimulus enters conscious thought and is processed too long, valuable time is lost—time that could mean survival or death, such as when avoiding a predator. Evolution has kept this predictive mechanism in the subconscious, bypassing slower, conscious thought.


So the placebo effect does not have a biophysiological function it is an offshoot of psychosomatism brought about by the brain's need for predictive behaviour.
Thus, the placebo effect is not a biophysiological function but an offshoot of the brain’s need for predictive behavior, connected to psychosomatic processes.


=== Placebo in practice ===
In practice, the ethical use of placebos by doctors presents a dilemma. A placebo only works if the patient believes it will, raising questions about honesty in treatment. Imagine a doctor prescribing a placebo for a patient, who experiences some benefit but misses out on a more effective treatment. In cases like depression, placebos have shown notable effects, but they are not guaranteed to be effective enough in all situations. For example, a placebo might not prevent a severely depressed patient from committing suicide.
Imagine you are a doctor with a placebo, you know it works only if the patient believes so ethically it's okay as ''a white lie?''. Then imagine the patient goes away and experiences the placebo effect but at the opportunity cost of receiving a non-placebo from somewhere else the doctor would be liable.


Take for example depression, there is a massive proven effect that a placebo has on the condition, there lots of examples of this<ref>Beckham, E. E. (1989). '''''Improvement after evaluation in psychotherapy of depression''': '''Evidence of a placebo effect?''' Journal of Clinical Psychology, 45(6), 945–950.'' doi:10.1002/1097-4679(198911)45:6<945::aid-jclp2270450620>3.0.co;2-2 </ref>, so why you ask doesn't a doctor just prescribe placebo on the first visit of a depressed patient to see if it works? One word, suicide. Imagine the doctor gives a placebo and then even though it may be effective, it isn't effective enough and the patient tragically commits suicide. There would more than likely be an investigation, where the doctor's notes on the consultation will be reviewed. In a court of law the MAY find the doctor negligible as they didn't prescribe harm reduction i.e. something that reduces suicide rates (like ssris) opposed to only a placebo.
If a doctor prescribes a placebo to a depressed patient and it proves insufficient, leading to a tragic outcome like suicide, the doctor could face serious legal consequences. In a court of law, a doctor might be found negligent for not prescribing more effective treatments, such as [[SSRI and psychedelics|SSRIs]], which are proven to reduce suicide risk. To avoid these risks, doctors often prioritize prescribing medications like SSRIs over placebos, even if a placebo might have some benefit. This approach ensures that they provide harm reduction and minimize liability, making the use of placebos less common in critical conditions like depression.


So in the doctor's mind, to avoid such issues as above it is less risky for them to prescribe SSRIs as opposed to a placebo in the first instance.), so why you ask doesn't a doctor just prescribe a placebo on the first visit of a depressed pat), so why you ask doesn't a doctor just prescribe placebo on the first visit of a depressed patient to see if it works? One word, suicide. Imagine the doctor gives a placebo and then even though it may be effective, it isn't effective enough and the patient tragically commits suicide. There would more than likely be an investigation, where the doctor's notes on the consultation will be reviewed. In a court of law, the MAY find the doctor negligible as they didn't prescribe harm reduction i.e. something that reduces suicide rates (like SSRIs) as opposed to only a placebo.
=== Placebo and Psychedelics ===
In one study<ref>'''Tripping on nothing: placebo psychedelics and contextual factors'''. Psychopharmacology (Berl). 2020 May;237(5):1371-1382. doi: 10.1007/s00213-020-05464-5. Epub 2020 Mar 7. Accessed 12 Sep 2024 via: https://pubmed.ncbi.nlm.nih.gov/32144438/
 
</ref> exploring the relationship between placebo and psychedelics T\thirty-three students completed a single-arm study ostensibly examining how a psychedelic drug affects creativity. The 4-h study took place in a group setting with music, paintings, coloured lights, and visual projections. Participants consumed a placebo that we described as a drug resembling psilocybin, which is found in psychedelic mushrooms. To boost expectations, confederates subtly acted out the stated effects of the drug and participants were led to believe that there was no placebo control group.The result of this study, showed '''t'''here was considerable individual variation in the placebo effects; many participants reported no changes while others showed effects with magnitudes typically associated with moderate or high doses of psilocybin. In addition, the majority (61%) of participants verbally reported some effect of the drug. Several stated that they saw the paintings on the walls "move" or "reshape" themselves, others felt "heavy… as if gravity [had] a stronger hold", and one had a "come down" before another "wave" hit her.
 
 
'''Reference'''

Revision as of 12:54, 12 September 2024

The Placebo Effect.
Figure 1. The Placebo Effect.

A placebo is a substance or treatment which is designed to have no therapeutic value. However, when administered to patients under the guise that it works, seemingly paradoxically an effect (termed the placebo effect) is shown (see Figure 1). This is thought to be caused, by priming via psychosomatic mechanisms.

Why does the placebo effect exist?

A key aspect of evolutionary success is the speed at which organisms respond to stimuli. Faster reactions increase survival rates, allowing those genes to persist in the species. This development is likened to an arms race, where genetic mutations evolve to enhance quick responses. Initially, simple chemical messengers were used, triggered by stimuli and resulting in responses, such as hormone release.

Over time, evolution improved these systems, leading to the creation of neurons, which could send electrical signals at incredible speed. Neurons allowed organisms to react in near real-time. However, evolution pushed further, and the brain developed into a predictive machine. Instead of just reacting, organisms could anticipate where a stimulus would occur, allowing them to respond even before the threat arrived. This ability gave species with larger brains, including humans, a significant competitive advantage in survival.

The placebo effect taps into this predictive mechanism. For the brain to make a quick prediction and act on it, the subconscious must believe the stimulus is real. If the stimulus enters conscious thought and is processed too long, valuable time is lost—time that could mean survival or death, such as when avoiding a predator. Evolution has kept this predictive mechanism in the subconscious, bypassing slower, conscious thought.

Thus, the placebo effect is not a biophysiological function but an offshoot of the brain’s need for predictive behavior, connected to psychosomatic processes.

In practice, the ethical use of placebos by doctors presents a dilemma. A placebo only works if the patient believes it will, raising questions about honesty in treatment. Imagine a doctor prescribing a placebo for a patient, who experiences some benefit but misses out on a more effective treatment. In cases like depression, placebos have shown notable effects, but they are not guaranteed to be effective enough in all situations. For example, a placebo might not prevent a severely depressed patient from committing suicide.

If a doctor prescribes a placebo to a depressed patient and it proves insufficient, leading to a tragic outcome like suicide, the doctor could face serious legal consequences. In a court of law, a doctor might be found negligent for not prescribing more effective treatments, such as SSRIs, which are proven to reduce suicide risk. To avoid these risks, doctors often prioritize prescribing medications like SSRIs over placebos, even if a placebo might have some benefit. This approach ensures that they provide harm reduction and minimize liability, making the use of placebos less common in critical conditions like depression.

Placebo and Psychedelics

In one study[1] exploring the relationship between placebo and psychedelics T\thirty-three students completed a single-arm study ostensibly examining how a psychedelic drug affects creativity. The 4-h study took place in a group setting with music, paintings, coloured lights, and visual projections. Participants consumed a placebo that we described as a drug resembling psilocybin, which is found in psychedelic mushrooms. To boost expectations, confederates subtly acted out the stated effects of the drug and participants were led to believe that there was no placebo control group.The result of this study, showed there was considerable individual variation in the placebo effects; many participants reported no changes while others showed effects with magnitudes typically associated with moderate or high doses of psilocybin. In addition, the majority (61%) of participants verbally reported some effect of the drug. Several stated that they saw the paintings on the walls "move" or "reshape" themselves, others felt "heavy… as if gravity [had] a stronger hold", and one had a "come down" before another "wave" hit her.


Reference

  1. Tripping on nothing: placebo psychedelics and contextual factors. Psychopharmacology (Berl). 2020 May;237(5):1371-1382. doi: 10.1007/s00213-020-05464-5. Epub 2020 Mar 7. Accessed 12 Sep 2024 via: https://pubmed.ncbi.nlm.nih.gov/32144438/

Share your opinion